“…Specifically for vitamins C and E, improvement in several physiological abnormalities induced by oxidative stress in SCA has been demonstrated, leading to reduction of dense cells and irreversibly sickled erythrocytes generation (Spielberg et al, 1979;McCall & Frei, 1999;Pryor, 2000;Amer & Fibach, 2004;Das et al, 2004;Krukoski et al, 2009). Other clinical trials with oral or parenteral antioxidant supplementation for several haemolytic conditions, such as thalassaemia (Kahane & Rachmilewitz, 1976;Giardini et al, 1985;Suthutvoravut et al, 1993;Tesoriere et al, 2001;Unchern et al, 2003;Dissayabutra et al, 2005;Kalpravidh et al, 2005;Palasuwan et al, 2006Palasuwan et al, , 2008Pfeifer et al, 2008), G-6-phosphate dehydrogenase deficiency (Eldamhougy et al, 1988;Sultana et al, 2008), anaemia in uraemic patients on haemodialysis (Ono, 1985;Nemeth et al, 2000;Candan & Gultekin, 2002), haemolytic anaemia during hepatitis C treatment (Saeian et al, 2004), snakebite-induced haemolysis Table VII). Only four of these studies evaluated VitC or VitE, alone or in combination with other drugs.…”